BACKGROUND: Papillon-Lefèvre syndrome (PLS; OMIM 245000) is a rare autosomal recessive disorder. Clinically, PLS is characterized by hyperkeratosis involving the palms, soles, elbows and knees which is followed later on by periodontitis, destruction of alveolar bone and loss of primary and permanent teeth. The condition is caused by mutations in the cathepsin C (CTSC) gene. METHODS: We analyzed the DNA of members from 3 consanguineous families for mutations in the CTSC gene by direct sequencing analysis. We then performed haplotype analysis. RESULTS: We identified an identical recurrent missense mutation, R272P, in all 3 families. Microsatellite marker analysis around the CTSC gene revealed the same haplotype on the mutation-carrying allele in all 3 families. CONCLUSION: The presence of this common mutation in families from 2 different geographical areas provides evidence for a founder effect for CTSC mutations in PLS. Copyright 2009 S. Karger AG, Basel.
BACKGROUND: Papillon-Lefèvre syndrome (PLS; OMIM 245000) is a rare autosomal recessive disorder. Clinically, PLS is characterized by hyperkeratosis involving the palms, soles, elbows and knees which is followed later on by periodontitis, destruction of alveolar bone and loss of primary and permanent teeth. The condition is caused by mutations in the cathepsin C (CTSC) gene. METHODS: We analyzed the DNA of members from 3 consanguineous families for mutations in the CTSC gene by direct sequencing analysis. We then performed haplotype analysis. RESULTS: We identified an identical recurrent missense mutation, R272P, in all 3 families. Microsatellite marker analysis around the CTSC gene revealed the same haplotype on the mutation-carrying allele in all 3 families. CONCLUSION: The presence of this common mutation in families from 2 different geographical areas provides evidence for a founder effect for CTSC mutations in PLS. Copyright 2009 S. Karger AG, Basel.
Authors: Y Zhang; T Lundgren; S Renvert; D N Tatakis; E Firatli; C Uygur; P S Hart; M C Gorry; J J Marks; T C Hart Journal: J Med Genet Date: 2001-02 Impact factor: 6.318
Authors: T C Hart; P S Hart; D W Bowden; M D Michalec; S A Callison; S J Walker; Y Zhang; E Firatli Journal: J Med Genet Date: 1999-12 Impact factor: 6.318
Authors: C Lefèvre; C Blanchet-Bardon; F Jobard; B Bouadjar; J F Stalder; S Cure; A Hoffmann; J F Prud'Homme; J Fischer Journal: J Invest Dermatol Date: 2001-12 Impact factor: 8.551
Authors: C Toomes; J James; A J Wood; C L Wu; D McCormick; N Lench; C Hewitt; L Moynihan; E Roberts; C G Woods; A Markham; M Wong; R Widmer; K A Ghaffar; M Pemberton; I R Hussein; S A Temtamy; R Davies; A P Read; P Sloan; M J Dixon; N S Thakker Journal: Nat Genet Date: 1999-12 Impact factor: 38.330
Authors: D Turk; V Janjić; I Stern; M Podobnik; D Lamba; S W Dahl; C Lauritzen; J Pedersen; V Turk; B Turk Journal: EMBO J Date: 2001-12-03 Impact factor: 11.598
Authors: T C Hart; P S Hart; M D Michalec; Y Zhang; M L Marazita; M Cooper; O M Yassin; M Nusier; S Walker Journal: J Med Genet Date: 2000-02 Impact factor: 6.318
Authors: Y Zhang; P S Hart; A J Moretti; O J Bouwsma; E M Fisher; L Dudlicek; M J Pettenati; T C Hart Journal: Hum Mutat Date: 2002-07 Impact factor: 4.878